To the central content area :::

Taipei Exchange

:::

Market Announcement



The ESB stock trading of Orient Pharma Co., Ltd. will be resumed from from May 16, 2022

Date: 2022/05/13

Since Orient Pharma Co., Ltd. (OP, Code:4166) had provided an explanation of the information relevant to the cause for the trading halt, TPEx announced trading in the shares of OP will be resumed on Emerging Stock Board from May 16, 2022.